Q3 2023 National Research Corp Earnings Call

Hello, everyone and welcome to the National Research Corporation third quarter 2023 earnings call. My name is Charlie and I will be coordinating the call. Today, you will have the opportunity to ask a question at the end of the presentation give you lots of register your question. Please press star followed by one on your <unk>.

One key pads.

I'll now hand over to our host Kevin Carroll Chief Financial Officer to begin Kevin. Please go ahead.

Thank you Charlie and welcome everyone to National Research Corporation's 2023 third quarter earnings call.

My name is Kevin <unk>, the company's CFO and joining me today on the call is when the Stacy our vice President of Finance before we continue I would ask Linda to review conditions related to any forward looking statements that may be made as a part of today's call Linda Thank you Ken.

This conference call includes forward looking statements related to the company that involve risks and uncertainties.

Could cause actual results or outcomes to differ materially from those currently anticipated. These forward looking statements are made pursuant to the safe Harbor provisions of the private Securities Litigation Reform Act of 1995 for further information about the facts that could affect the company's future results. Please see the company's filings with the Securities and Exchange Commission.

I'll turn it back to you Kevin.

Thanks Linda.

This quarter was a good start on our plan to accelerate revenue growth and expand margins over the coming quarters, we have seen sales and margin improving sequentially. The past two quarters with only partial implementation of the plan.

I will cover three topics to set the stage for where we're headed before Linda covers the financial metrics.

First new sales and.

NRC health is a leader in helping healthcare providers improve their patient experience on an individualized basis, using decades of benchmarking and our unique ability to translate data into actionable advice.

Our human understanding program released in the second quarter of 2022.

Has become widely accepted in the market with 91 health care provider systems adopting human understanding 18.

Percent of which were from new logos.

Our contract value growth for the human understanding program adoption by existing clients is averaging 13%, which is in line with the results. We saw from the successful rollout of our real time solutions several years ago.

Yeah.

And these results so far have been without the benefit of a fully developed sales force.

To capitalize on the growing demand the size of our sales force.

<unk> has been increased by 19% since the beginning of the year and we expect to continue to add experienced personnel in this area.

The expansion of sales and marketing resources has been successful in building, our sales pipeline and producing two consecutive quarters of double digit sales growth compared to prior year.

We expect to see the results of these efforts.

Flow through to revenue and Trc V in future periods.

Second is margin expansion, while increasing our sales force we have reduced the.

The number of non sales personnel.

On a net basis, we have decreased the full time equivalent number of associates by 11% at the end of the third quarter of 2023 compared to the end of third quarter of 2022.

Most of that decrease occurred during the third quarter of 2023 and the related cost reduction has not yet been fully reflected we expect to see the results of these efforts.

<unk> revenue per associate and operating margin in future periods.

Thirdly, we are highly cognizant of our clients' desire for solutions across multiple patient customer and employee experiences.

With our continued product development and partner alliances, we are expanding our product offerings to take advantage of a much larger existing total addressable market, while gaining market share in our core patient experience market.

With that let me turn the call back to Linda to review, our financial performance and then open the call to any questions. Thank.

Thank you Kevin revenue for the third quarter 2023 increased slightly compared to the third quarter of 2022.

We ended the quarter with $124 $3 million in Trc D or Trc metric represents a total revenue projected under all renewable contracts.

Are the respective next annual renewal periods.

Assuming no upsell down sales price increases or cancellation measured as the most recent quarter end.

Operating income decreased by 10%.

For the third quarter of 2023 compared to the third quarter of 2022.

Early data growth and certain cost exceeding revenue growth.

Increased investments were made in marketing expenses of 343000.

Excuse me to expand brand recognition as the part sales development and additional cyber security and other software services of 292000.

In addition, we incurred 661000 of expense and non recurring state tax incentive adjustment.

The effective tax rate in the third quarter of 2023.

Was 22% compared to 23% in 2022, primarily due to lower state.

Primarily due to lower state income taxes of 313000, partially offset by decreased tax benefit of 138000 from exercise of share based compensation Awards.

Operating margin grew by 3% over the second quarter of 2023 due to revenue growth outpacing operating expense growth.

Force reductions and other cost alignment changes implemented during the quarter will enable continued margin improvement in future quarters.

Company remains well positioned to execute the entire range of capital allocation alternatives.

<unk> funding for innovation and growth investments shareholder dividends and share repurchases.

At September 32023, the company had approximately $20 million and net debt and $25 million available on the line of credit after funding $3 7 million for innovation and growth $27 5 million for dividend payments and 310000 for share repurchases in the third quarter that concludes my comments.

This morning, I'll now turn the call back to Kevin.

Thank you Linda.

This completes our prepared remarks, so Charlie I will now ask you to open the call to any questions.

Thank you of course, if you'd like to ask a question. Please press star followed by one on your telephone keypad, if you're allowed to be truly a question. Please press star followed by two when preparing to ask a question. Please ensure you're on mute locally as a reminder, that star followed by one on your telephone keypad now we will pause briefly to allow for any question.

You bet.

At this stage, we have no questions registered so I'll hand back over to the management team for any concluding remarks.

Well. Thank you for your time today, we look forward to sharing our results again next quarter.

Ladies and gentlemen. This concludes today's call. Thank you for joining you may now disconnect your lines.

[music].

Okay.

Ladies and gentlemen, this concludes today's call. Thank you for joining you may now disconnect.

Q3 2023 National Research Corp Earnings Call

Demo

NRC Health

Earnings

Q3 2023 National Research Corp Earnings Call

NRC

Wednesday, November 8th, 2023 at 4:00 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →